Early Tumor Necrosis Factor Inhibitor Initiation and Chronic Opioid Use in Individuals with Axial Spondyloarthritis

被引：0
|
作者：
Petrow, Eva [1 ,2 ]
Aguilar, Jose Meade [2 ]
Peloquin, Christine [3 ]
Jafarzadeh, S. Reza [3 ]
Neogi, Tuhina [3 ]
Dubreuil, Maureen [4 ]
Liew, Jean [3 ]
机构：
[1] Boston Univ, Boston, MA USA
[2] Boston Med Ctr, Boston, MA USA
[3] Boston Univ, Chobanian & Avedisian Sch Med, Boston, MA USA
[4] Boston Univ, Sch Med, Sect Rheumatol, Boston, MA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1892
引用
收藏
页码：3846 / 3848
页数：3
相关论文
共 50 条
  • [1] Personalized tapering of tumor necrosis factor inhibitor in axial spondyloarthritis
    Huang, Jin-Xian
    Lee, Yung-Heng
    Leong, Pui-Ying
    Wei, James Cheng-Chung
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (01)
  • [2] Effectiveness of Tumor Necrosis Factor α Blockers in Early Axial Spondyloarthritis
    Molto, Anna
    Paternotte, Simon
    Claudepierre, Pascal
    Breban, Maxime
    Dougados, Maxime
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 (07) : 1734 - 1744
  • [3] Profiling Response to Tumor Necrosis Factor Inhibitor Treatment in Axial Spondyloarthritis
    Alazmi, Mansour
    Sari, Ismail
    Krishnan, Bharath
    Inman, Robert D.
    Haroon, Nigil
    ARTHRITIS CARE & RESEARCH, 2018, 70 (09) : 1393 - 1399
  • [4] Tumor Necrosis Factor Inhibitor Persistence and Reasons for Discontinuation in US Veterans with Axial Spondyloarthritis
    Bekele, Delamo
    Cheng, Elizabeth
    Geier, Christian
    Ganuthula, Kavya
    Walsh, Jessica
    Dubreuil, Maureen
    Clegg, Daniel O.
    Kaushik, Prashant
    Ng, Bernard
    Chang, Elizabeth
    Reimold, Andreas
    Raychaudhuri, Siba P.
    Duong, Ryan
    Kuhn, Kristine A.
    Park, Yujin
    Kerr, Gail S.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [5] Extraskeletal Manifestations in Axial Spondyloarthritis Are Associated With Worse Clinical Outcomes Despite the Use of Tumor Necrosis Factor Inhibitor Therapy
    van der Meer, Rienk
    Arends, Suzanne
    Kruidhof, Sandra
    Bos, Reinhard
    Bootsma, Hendrika
    Wink, Freke
    Spoorenberg, Anneke
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (02) : 157 - 164
  • [6] Switching tumor necrosis factor inhibitors in the treatment of axial spondyloarthritis
    Deodhar, Atul
    Yu, David
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2017, 47 (03) : 343 - 350
  • [7] Tumor necrosis factor alpha antagonists in the treatment of axial spondyloarthritis
    Braun, Juergen
    Baraliakos, Xenofon
    Heldmann, Frank
    Kiltz, Uta
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (05) : 647 - 659
  • [8] Tumor necrosis factor inhibitor (TNFi) persistence and reasons for discontinuation in a predominantly male cohort with axial spondyloarthritis
    Bekele, Delamo I.
    Cheng, Elizabeth
    Reimold, Andreas
    Geier, Christian
    Ganuthula, Kavya
    Walsh, Jessica A.
    Clegg, Daniel O.
    Dubreuil, Maureen
    Kaushik, Prashant
    Ng, Bernard
    Chang, Elizabeth
    Duong, Ryan
    Park, Jina
    Kerr, Gail S.
    RHEUMATOLOGY INTERNATIONAL, 2022, 42 (11) : 1925 - 1937
  • [9] Tumor necrosis factor inhibitor (TNFi) persistence and reasons for discontinuation in a predominantly male cohort with axial spondyloarthritis
    Delamo I. Bekele
    Elizabeth Cheng
    Andreas Reimold
    Christian Geier
    Kavya Ganuthula
    Jessica A. Walsh
    Daniel O. Clegg
    Maureen Dubreuil
    Prashant Kaushik
    Bernard Ng
    Elizabeth Chang
    Ryan Duong
    Jina Park
    Gail S. Kerr
    Rheumatology International, 2022, 42 : 1925 - 1937
  • [10] EFFECT OF SWITCHING BETWEEN TUMOR NECROSIS FACTOR INHIBITOR IN SPONDYLOARTHRITIS
    ben Abla, Hedia
    Rekik, Sonia
    Boussaid, Soumaya
    Jammali, Samia
    Sahli, Hela
    Cheour, Elhem
    Elleuch, Mohamed
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1811 - 1811
12345